1. Home
  2. IGIC vs MDXG Comparison

IGIC vs MDXG Comparison

Compare IGIC & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International General Insurance Holdings Ltd.

IGIC

International General Insurance Holdings Ltd.

HOLD

Current Price

$24.55

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$4.66

Market Cap

625.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IGIC
MDXG
Founded
2001
2006
Country
Jordan
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
625.6M
IPO Year
2019
2007

Fundamental Metrics

Financial Performance
Metric
IGIC
MDXG
Price
$24.55
$4.66
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
★ $28.00
$9.00
AVG Volume (30 Days)
67.1K
★ 942.2K
Earning Date
05-05-2026
04-29-2026
Dividend Yield
★ 5.25%
N/A
EPS Growth
N/A
★ 14.29
EPS
★ N/A
N/A
Revenue
N/A
★ $418,630,000.00
Revenue This Year
$0.13
N/A
Revenue Next Year
$2.54
$13.02
P/E Ratio
$9.05
★ N/A
Revenue Growth
N/A
★ 19.99
52 Week Low
$20.82
$3.03
52 Week High
$29.59
$7.97

Technical Indicators

Market Signals
Indicator
IGIC
MDXG
Relative Strength Index (RSI) 32.63 52.64
Support Level $24.51 $4.11
Resistance Level $25.97 $4.76
Average True Range (ATR) 0.58 0.19
MACD -0.11 -0.01
Stochastic Oscillator 11.43 40.68

Price Performance

Historical Comparison
IGIC
MDXG

About IGIC International General Insurance Holdings Ltd.

International General Insurance Holdings Ltd is an international specialty insurance and reinsurance group. It underwrites a diversified portfolio of specialty risks including energy, property, construction and engineering, ports and terminals, general aviation, political violence, professional lines, financial institutions, marine, contingency and treaty reinsurance. The company's operating segments include Specialty Longtail, Specialty Short tail and Reinsurance. The majority of revenue is derived from the Specialty Short-tail segment, which comprises business lines with underwriting risks assumed in the form of property and specialty lines insurance and of short-term nature with respect to related claims.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: